FDAnews Drug Daily Bulletin

LAM PHARMACEUTICAL CORP. RE-LAUNCHES ITS SEXUAL DYSFUNCTION TREATMENT PRODUCTS

Nov. 23, 2005
A A

LAM Pharmaceutical, Corp. (OTCBB: LAMP ; Frankfurt: LAM ; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today the re-launch of its patented proprietary Sexual Dysfunction Treatment Products, which are based on LAM's novel IPM Ionic Polymer Matrix. Following the cancellation for non-payment of the license to Ixora Biomedical, LAM has granted a worldwide license (with the notable exception of China) for the sexual dysfunction treatment product group to the Cayman Islands based international marketing company Exoris Inc.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-22-2005/0004221158&EDATE=)